Related Experiment Videos
5-Fluorocytosine and Candida yeasts
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|February 1, 1987
Summary
5-fluorocytosine shows lower efficacy against Candida non-albicans compared to Candida albicans. This antifungal drug inhibits 83% of C. albicans but only 40% of C. non-albicans strains tested.
Area of Science:
- Mycology
- Antimicrobial drug research
- Infectious diseases
Background:
- Candida species are significant human pathogens.
- Antifungal resistance is a growing concern.
- 5-fluorocytosine is an established antifungal agent.
Purpose of the Study:
- To evaluate the in vitro activity of 5-fluorocytosine against clinical isolates of Candida species.
- To compare the susceptibility of Candida albicans and Candida non-albicans to 5-fluorocytosine.
Main Methods:
- Broth microdilution method was used for susceptibility testing.
- Minimum Inhibitory Concentration (MIC) and Minimum Lethal Concentration (MLC) were determined.
- 101 Candida albicans and 42 Candida non-albicans strains were tested.
Main Results:
- A concentration of 1.56 microgram/ml 5-fluorocytosine inhibited 83% of Candida albicans strains.
- The same concentration inhibited only 40% of Candida non-albicans strains.
- 5-fluorocytosine demonstrated significantly lower inhibitory and lethal activity against non-albicans Candida species.
Conclusions:
- 5-fluorocytosine exhibits variable activity against different Candida species.
- Clinical use of 5-fluorocytosine may require species-specific susceptibility testing.
- Further research into optimizing antifungal strategies for non-albicans Candida infections is warranted.